Studying the Arms Race Between Bacteria and Viruses

Article

Dr. Asma Hatoum-Aslan, UA assistant professor of biological sciences, was recently awarded a National Science Foundation CAREER Award to continue her work in discovering how bacterial immune systems ward off bacteriophages, or viruses that specifically attack bacteria.

“We’re looking at both sides of the coin,” she said. “We’re interested in how defense mechanisms collaborate with other processes inside the cell to mount a more effective defense, but also the offensive mechanisms that phages use to overcome these defenses. We’re looking at both sides of the phage-host arms race.”

The human body hosts all sorts of bacteria and their accompanying phages. In fact, phages are 10 times more abundant than bacteria in every environment tested, and they are all part of what scientists call our microbiome. There is limited knowledge about what transpires between phages and their bacterial hosts within the microbiome.

In this project, Staphylococcus bacteria and their phages, both abundant residents of human skin, will be used as a model host-virus system. Hatoum-Aslan and her students discovered a suite of new Staphylococcus phages from local wastewater to use for this research.

Historically, research focused on the ongoing battle between bacteria and phage led to groundbreaking discoveries such as the immune system commonly referred to as CRISPR-Cas, which has since sparked a genome editing revolution.

CRISPR-Cas systems are sequences of genetic code inside bacteria that also store snippets of phage code. The CRISPR-Cas system uses the stored phage code to “remember” past invaders. When a phage invader with matching code is encountered again, CRISPR-associated enzymes cut apart the genetic sequences in invading phages, destroying them.

Scientists are able to manipulate this process to edit genetic code in a wide-range of organisms, including humans. The most commonly used system to date is CRISPR-Cas9, but Hatoum-Aslan is studying the more complex and less understood CRISPR-Cas10 system.

“There are really no applications for CRISPR-Cas10 outside of what we have basically developed, which is engineering phage genomes,” she said. “CRISPR-Cas10 is not the ‘go to’ CRISPR system for any sort of genome editing application, but it appears that it’s particularly suited for editing phage genomes.”

Her lab found that CRISPR-Cas10 collaborates with other systems in the bacterial cell not traditionally thought of as taking part in phage defense. This feature allows CRISPR-Cas10 to essentially decimate invading phages, leaving no survivors.

“Because CRISPR-Cas10 is so effective in battling phages, its robustness makes it an ideal system for phage genome editing,” Hatoum-Aslan said.

“Discovering new phages is an essential part of studying CRISPR-Cas10 and other anti-phage defense mechanisms,” she said. “The more diverse phages we have in our collection, the better we will be able to understand how bacteria cope with them in distinct ways.”

For this project, she and her team are focused on discovery and understanding, but this work could lead to novel ways to tailor phages or the immune systems that protect against them as treatments for bacterial infections.

“There are potentially far reaching applications of the work, particularly in combating antibiotic resistant infections, but before applications can be developed, it is essential to gain a basic understanding of how these defensive and offensive mechanisms work at the molecular level,” Hatoum-Aslan said.

The grant also allows her to continue development of educational modules and a week-long curriculum for high schools that teach microbiology through hands-on experiments with bacteria and their phages.

The Faculty Early Career Development, or CAREER, Program is a Foundation-wide activity that offers the NSF’s most prestigious awards in support of early-career faculty who have the potential to serve as academic role models in research and education and to lead advances in the mission of their department or organization.

Source:  University of Alabama

Recent Videos
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Related Content